Supplementation with Hydroxytyrosol and Punicalagin Improves Early Atherosclerosis Markers Involved in the Asymptomatic Phase of Atherosclerosis in the Adult Population: A Randomized, Placebo-Controlled, Crossover Trial
Hydroxytyrosol (HT) and Punicalagin (PC) exert cardioprotective and anti-atherosclerotic effects. This study evaluates the effect of oral supplementation with HT and PC (SAx) on early atherosclerosis markers in middle-aged, seemingly healthy adults. A randomized, double-blinded, placebo-controlled,...
Main Authors: | Rebeca Quirós-Fernández, Bricia López-Plaza, Laura M. Bermejo, Samara Palma-Milla, Carmen Gómez-Candela |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6643/11/3/640 |
Similar Items
-
Punicalagin Regulates Key Processes Associated with Atherosclerosis in THP-1 Cellular Model
by: Sanaa Almowallad, et al.
Published: (2020-11-01) -
Hydroxytyrosol and its main plasma circulating metabolites attenuate the initial steps of atherosclerosis through inhibition of the MAPK pathway
by: Úrsula Catalán, et al.
Published: (2018-01-01) -
Hydroxytyrosol Acetate Inhibits Vascular Endothelial Cell Pyroptosis via the HDAC11 Signaling Pathway in Atherosclerosis
by: Feng Yao, et al.
Published: (2021-04-01) -
Punicalagin Attenuates Disturbed Flow-Induced Vascular Dysfunction by Inhibiting Force-Specific Activation of Smad1/5
by: Gulinigaer Anwaier, et al.
Published: (2021-06-01) -
Effect of punicalagin on proliferation of porcine ovarian granulosa cells in vitro
by: Dagmara Packová, et al.
Published: (2016-12-01)